Thu, Sep 18, 2014, 11:35 AM EDT - U.S. Markets close in 4 hrs 25 mins

Recent

% | $
Quotes you view appear here for quick access.

Agile Therapeutics, Inc. Message Board

sdex47a 1 post  |  Last Activity: Aug 15, 2014 5:28 PM Member since: Jul 1, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • This company appeared on my screens today so I did some research including looking at the 10Q. The company IPOd 3 months ago. AGRX has a once-a-week birth control patch that is in a phase 3 trial. This product, Twirla, should be approved in the next 2 years and would result in sales of 200-400mil/year. This stock could easily double from it's current $130 million dollar market cap. Guru Investor Chuck Royce recently took a large position along with several other hedge fund investors according to the SEC filings (13d). There are lots of risks associated with this company. It has no current product and there is no guarantee it will receive approval or that it's product will capture much market share. There are several other companies with similar products. Twirla is unique in it's low dosing of hormones. This appears significant since other products have been pulled due to higher hormone levels causing problems. Twirla seems a good prospect. The 10Q states it might be available commercially by the end of 2016. Because of the size of this company, it would not take a large market share of the birth control patch market to make a significant price change in the stock. I think it's worth a small bet.

AGRX
8.55+0.35(+4.27%)11:32 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.